Chiome Bioscience

Chiome Bioscience EBIT per Share

The EBIT per Share of Chiome Bioscience (4583.T) as of Oct 11, 2026 is -14.39 JPY. In the previous year, EBIT per Share was -16.16 JPY — a change of -10.97% (higher).

EBIT per Share

-14.39JPY

YoY

-10.97%

Last updated:

EBIT per Share of Chiome Bioscience is 2025 -14.39 JPY. EBIT per Share of Chiome Bioscience was 2024 -16.16 JPY. It decreases by -10.97% higher compared to the previous year.

The Chiome Bioscience EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2019
-42.12 JPY
Jan 1, 2020
-32.67 JPY
Jan 1, 2021
-36.12 JPY
Jan 1, 2022
-26.89 JPY
Jan 1, 2023
-23.30 JPY
Jan 1, 2024
-16.16 JPY
Jan 1, 2025
-14.39 JPY
Jan 1, 2026 (e)
0.00 JPY
The Chiome Bioscience EBIT per Share history
YEAREBIT per ShareYoY
est0.00JPY-100.00%
-14.39JPY-10.97%
-16.16JPY-30.66%
-23.30JPY-13.35%
-26.89JPY-25.54%
-36.12JPY+10.55%
-32.67JPY-22.44%
-42.12JPY-26.71%
-57.47JPY+73.35%
-33.15JPY-25.02%
-44.22JPY-23.50%
-57.80JPY+8.43%
-53.30JPY+468.97%
-9.37JPY+71.60%
-5.46JPY+5,586.21%
-0.10JPY-96.86%
-3.05JPY+14.74%
-2.66JPY-5.40%
-2.81JPY-81.46%
-15.18JPY+28.43%
-11.82JPY—
Access this data via the Eulerpool API
Get Free API Key

Chiome Bioscience Stock analysis

What does Chiome Bioscience do? Chiome Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Chiome Bioscience stock

EBIT per Share of Chiome Bioscience is -14.39 JPY in 2025.

EBIT per Share of Chiome Bioscience changed from -16.16 JPY to -14.39 JPY, representing a -10.97% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Chiome Bioscience since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Chiome Bioscience

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Chiome Bioscience